These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1708922)

  • 1. VAB-6 chemotherapy causes spurious elevation of alpha-fetoprotein associated with liver dysfunctions.
    Hida S; Nishimura K; Nishio Y; Oishi K; Takeuchi H; Yoshida O
    Urol Int; 1991; 46(1):1-5. PubMed ID: 1708922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [False-positive elevation of alpha-fetoprotein during induction chemotherapy in patients with testicular cancer].
    Hida S; Kawakita M; Oishi K; Okada Y; Takeuchi H; Okada K; Yoshida O
    Hinyokika Kiyo; 1986 Dec; 32(12):1859-66. PubMed ID: 2435135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case report of a 6-year-old boy with intracranial yolk sac tumor treated by VAB-6 regimen].
    Wada H; Kubo M; Wada T; Ueno Y; Horita S; Ohki T; Munemoto S; Kuroda E; Taguchi H; Muramatsu N
    No Shinkei Geka; 1995 Jan; 23(1):65-8. PubMed ID: 7531296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pattern of gamma-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase in patients with disseminated non-seminomatous testicular tumors.
    van 't Sant P; Sleijfer DT; Schraffordt Koops H; Suurmeijer AJ; Willemse PH; De Bruijn HW; Marrink J; Ockhuizen T
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):209-15. PubMed ID: 6200328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case report of a non-seminomatous testicular neoplasm indicating marked efficacy of a combination chemotherapy of VBL, ACTD, BLM, CDDP and EX (VAB-4 combination therapy)].
    Hayashi M; Ebihara K; Urano E
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2775-7. PubMed ID: 6210063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modified VAB-3 combination chemotherapy of stage IV endodermal sinus tumor of the ovary].
    Tsukamoto N; Imachi M; Sumioki H; Kamura T
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):948-51. PubMed ID: 6202244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of the use of bleomycin and its analogs in the VAB-6 protocol in treating testicular tumors].
    Garin AM; Tiuliandin SA; Abdyldaev TA; Khlebnov AV; Kupchan DZ
    Antibiot Khimioter; 1988 Nov; 33(11):855-9. PubMed ID: 2465746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.
    Mencel PJ; Motzer RJ; Mazumdar M; Vlamis V; Bajorin DF; Bosl GJ
    J Clin Oncol; 1994 Jan; 12(1):120-6. PubMed ID: 7505805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
    Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
    Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
    de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
    Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early changes in serum alpha-fetoprotein after chemotherapy in advanced testicular tumors].
    Yamazaki H; Kondo N; Imanaka K; Kuroda A; Nakauchi K; Machida T
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1010-6. PubMed ID: 1699019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
    Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
    J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VAB-6 as initial treatment of patients with advanced seminoma.
    Stanton GF; Bosl GJ; Whitmore WF; Herr H; Sogani P; Morse M; Golbey RB
    J Clin Oncol; 1985 Mar; 3(3):336-9. PubMed ID: 2579214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified VAB-3 combination chemotherapy of advanced and recurrent endodermal sinus tumors of the ovary.
    Tsukamoto N; Imachi M; Uchino H; Ono M; Kamura T; Saito T; Matsukuma K
    Gynecol Oncol; 1985 Mar; 20(3):336-45. PubMed ID: 2579009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VAB-6 combination chemotherapy in disseminated cancer of the testis.
    Vugrin D; Herr HW; Whitmore WF; Sogani PC; Golbey RB
    Ann Intern Med; 1981 Jul; 95(1):59-61. PubMed ID: 6166230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
    Grem JL; Trump DL
    J Clin Oncol; 1986 Jan; 4(1):41-5. PubMed ID: 2416888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VAB-3 chemotherapy of endodermal sinus tumor of the ovary].
    Goto Y; Imai K; Yamashita M; Konishi I; Fujii S; Noda Y; Okamura H; Mori T; Suzuki A
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):75-80. PubMed ID: 2440967
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of complete remission obtained with etoposide cis-platinum combination chemotherapy in advanced testicular cancer].
    Iinuma S; Yamamoto H; Hagiwara M; Nakazono M
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):293-6. PubMed ID: 1689134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management and drug therapy of patients with disseminated testicular tumors].
    Garin AM; Lichinitser MR; Khlebnov AV; Tiuliandin SA
    Vopr Onkol; 1986; 32(10):71-8. PubMed ID: 2430361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
    Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
    J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.